Glycosylation-Dependent IFN-γR Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation

Cell

Volumn 166, Issue 4, 2016, Pages 920-934

  Blouin, Cédric M ^a   Hamon, Yannick ^b   Gonnord, Pauline ^c   Boularan, Cédric ^d   Kagan, Jérémy ^a   Viaris de Lesegno, Christine ^a   Ruez, Richard ^a   Mailfert, Sébastien ^b   Bertaux, Nicolas ^e   Loew, Damarys ^a   Wunder, Christian ^a   Johannes, Ludger ^a   Vogt, Guillaume ^f,g,h   Contreras, Francesc Xabier ^i,j,k   Marguet, Didier ^b   Casanova, Jean Laurent ^f,g,h,l   Galès, Céline ^d   He, Hai Tao ^b   Lamaze, Christophe ^a  

^a INSTITUT CURIE   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c University of Toulouse III   (France)

^d Université de Toulouse   (France)

^e AIX MARSEILLE UNIVERSITÉ   (France)

^f ROCKEFELLER UNIVERSITY   (United States)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ CSIC UPV Unidad de Biofisica UBF   (Spain)

^j UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^k BASQUE FOUNDATION FOR SCIENCE   (Spain)

^l HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHOLESTEROL; GALECTIN; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; JANUS KINASE; LIPID; SPHINGOLIPID; STAT PROTEIN; UNCLASSIFIED DRUG; GAMMA INTERFERON; IFNGR2 PROTEIN, HUMAN; INTERFERON RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STIMULATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; ANIMAL; CELL MEMBRANE; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS CELL LINE; DIFFUSION; ENDOCYTOSIS; GENETICS; IMMUNOLOGY; METABOLISM; MISSENSE MUTATION; MYCOBACTERIOSIS; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; DIFFUSION; ENDOCYTOSIS; ENZYME ACTIVATION; FIBROBLASTS; GLYCOSYLATION; HUMANS; INTERFERON-GAMMA; MUTATION, MISSENSE; MYCOBACTERIUM INFECTIONS; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION;

EID: 84981318493     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.07.003     Document Type: Article

References (40)

1. Babon, J.J., Lucet, I.S., Murphy, J.M., Nicola, N.A., Varghese, L.N., The molecular regulation of Janus kinase (JAK) activation. Biochem. J. 462 (2014), 1–13.
2. Bacart, J., Corbel, C., Jockers, R., Bach, S., Couturier, C., The BRET technology and its application to screening assays. Biotechnol. J. 3 (2008), 311–324.
3. Billaudeau, C., Mailfert, S., Trombik, T., Bertaux, N., Rouger, V., Hamon, Y., He, H.T., Marguet, D., Probing the plasma membrane organization in living cells by spot variation fluorescence correlation spectroscopy. Methods Enzymol. 519 (2013), 277–302.
4. Blouin, C.M., Lamaze, C., Interferon gamma receptor: the beginning of the journey. Front. Immunol., 4, 2013, 267.
5. Brooks, A.J., Dai, W., O'Mara, M.L., Abankwa, D., Chhabra, Y., Pelekanos, R.A., Gardon, O., Tunny, K.A., Blucher, K.M., Morton, C.J., et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344, 2014, 1249783.
6. Bustamante, J., Boisson-Dupuis, S., Abel, L., Casanova, J.L., Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin. Immunol. 26 (2014), 454–470.
7. Chen, I.J., Chen, H.L., Demetriou, M., Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling. J. Biol. Chem. 282 (2007), 35361–35372.
8. Chung, A.W., Sieling, P.A., Schenk, M., Teles, R.M., Krutzik, S.R., Hsu, D.K., Liu, F.T., Sarno, E.N., Rea, T.H., Stenger, S., et al. Galectin-3 regulates the innate immune response of human monocytes. J. Infect. Dis. 207 (2013), 947–956.
9. Claudinon, J., Gonnord, P., Beslard, E., Marchetti, M., Mitchell, K., Boularan, C., Johannes, L., Eid, P., Lamaze, C., Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha. J. Biol. Chem. 284 (2009), 24328–24340.
10. Contreras, F.X., Ernst, A.M., Haberkant, P., Björkholm, P., Lindahl, E., Gönen, B., Tischer, C., Elofsson, A., von Heijne, G., Thiele, C., et al. Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 481 (2012), 525–529.
11. Dennis, J.W., Brewer, C.F., Density-dependent lectin-glycan interactions as a paradigm for conditional regulation by posttranslational modifications. Mol. Cell. Proteomics 12 (2013), 913–920.
12. Dennis, J.W., Nabi, I.R., Demetriou, M., Metabolism, cell surface organization, and disease. Cell 139 (2009), 1229–1241.
13. Dorman, S.E., Holland, S.M., Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101 (1998), 2364–2369.
14. Freeze, H.H., Genetic defects in the human glycome. Nat. Rev. Genet. 7 (2006), 537–551.
15. Galés, C., Van Durm, J.J., Schaak, S., Pontier, S., Percherancier, Y., Audet, M., Paris, H., Bouvier, M., Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat. Struct. Mol. Biol. 13 (2006), 778–786.
16. Gowrishankar, K., Ghosh, S., Saha, S., C, R., Mayor, S., Rao, M., Active remodeling of cortical actin regulates spatiotemporal organization of cell surface molecules. Cell 149 (2012), 1353–1367.
17. Hamdan, F.F., Percherancier, Y., Breton, B., Bouvier, M., Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET). Curr. Protoc. Neurosci., Chapter 5, 2006 Unit 5.23.
18. Issad, T., Blanquart, C., Gonzalez-Yanes, C., The use of bioluminescence resonance energy transfer for the study of therapeutic targets: application to tyrosine kinase receptors. Expert Opin. Ther. Targets 11 (2007), 541–556.
19. Krause, C.D., Pestka, S., Historical developments in the research of interferon receptors. Cytokine Growth Factor Rev. 18 (2007), 473–482.
20. Krause, C.D., Mei, E., Xie, J., Jia, Y., Bopp, M.A., Hochstrasser, R.M., Pestka, S., Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells. Mol. Cell. Proteomics 1 (2002), 805–815.
21. Krause, C.D., Lavnikova, N., Xie, J., Mei, E., Mirochnitchenko, O.V., Jia, Y., Hochstrasser, R.M., Pestka, S., Preassembly and ligand-induced restructuring of the chains of the IFN-gamma receptor complex: the roles of Jak kinases, Stat1 and the receptor chains. Cell Res. 16 (2006), 55–69.
22. Kusumi, A., Fujiwara, T.K., Chadda, R., Xie, M., Tsunoyama, T.A., Kalay, Z., Kasai, R.S., Suzuki, K.G., Dynamic organizing principles of the plasma membrane that regulate signal transduction: commemorating the fortieth anniversary of Singer and Nicolson's fluid-mosaic model. Annu. Rev. Cell Dev. Biol. 28 (2012), 215–250.
23. Kusumi, A., Fujiwara, T.K., Morone, N., Yoshida, K.J., Chadda, R., Xie, M., Kasai, R.S., Suzuki, K.G., Membrane mechanisms for signal transduction: the coupling of the meso-scale raft domains to membrane-skeleton-induced compartments and dynamic protein complexes. Semin. Cell Dev. Biol. 23 (2012), 126–144.
24. Lajoie, P., Partridge, E.A., Guay, G., Goetz, J.G., Pawling, J., Lagana, A., Joshi, B., Dennis, J.W., Nabi, I.R., Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 179 (2007), 341–356.
25. Lasserre, R., Guo, X.J., Conchonaud, F., Hamon, Y., Hawchar, O., Bernard, A.M., Soudja, S.M., Lenne, P.F., Rigneault, H., Olive, D., et al. Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat. Chem. Biol. 4 (2008), 538–547.
26. Lenne, P.F., Wawrezinieck, L., Conchonaud, F., Wurtz, O., Boned, A., Guo, X.J., Rigneault, H., He, H.T., Marguet, D., Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J. 25 (2006), 3245–3256.
27. Lingwood, D., Simons, K., Lipid rafts as a membrane-organizing principle. Science 327 (2010), 46–50.
28. Lohse, M.J., Nuber, S., Hoffmann, C., Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling. Pharmacol. Rev. 64 (2012), 299–336.
29. Marchetti, M., Monier, M.N., Fradagrada, A., Mitchell, K., Baychelier, F., Eid, P., Johannes, L., Lamaze, C., Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol. Biol. Cell 17 (2006), 2896–2909.
30. Nabi, I.R., Shankar, J., Dennis, J.W., The galectin lattice at a glance. J. Cell Sci. 128 (2015), 2213–2219.
31. Platanias, L.C., Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5 (2005), 375–386.
32. Rabinovich, G.A., Toscano, M.A., Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9 (2009), 338–352.
33. Raghupathy, R., Anilkumar, A.A., Polley, A., Singh, P.P., Yadav, M., Johnson, C., Suryawanshi, S., Saikam, V., Sawant, S.D., Panda, A., et al. Transbilayer lipid interactions mediate nanoclustering of lipid-anchored proteins. Cell 161 (2015), 581–594.
34. Rao, M., Mayor, S., Active organization of membrane constituents in living cells. Curr. Opin. Cell Biol. 29 (2014), 126–132.
35. Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 387 (1997), 569–572.
36. Stark, G.R., Darnell, J.E. Jr., The JAK-STAT pathway at twenty. Immunity 36 (2012), 503–514.
37. Thompson, J.E., Cubbon, R.M., Cummings, R.T., Wicker, L.S., Frankshun, R., Cunningham, B.R., Cameron, P.M., Meinke, P.T., Liverton, N., Weng, Y., DeMartino, J.A., Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg. Med. Chem. Lett. 12 (2002), 1219–1223.
38. van Boxel-Dezaire, A.H., Stark, G.R., Cell type-specific signaling in response to interferon-gamma. Curr. Top. Microbiol. Immunol. 316 (2007), 119–154.
39. Vogt, G., Chapgier, A., Yang, K., Chuzhanova, N., Feinberg, J., Fieschi, C., Boisson-Dupuis, S., Alcais, A., Filipe-Santos, O., Bustamante, J., et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat. Genet. 37 (2005), 692–700.
40. Vogt, G., Bustamante, J., Chapgier, A., Feinberg, J., Boisson Dupuis, S., Picard, C., Mahlaoui, N., Gineau, L., Alcaïs, A., Lamaze, C., et al. Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation. J. Exp. Med. 205 (2008), 1729–1737.